What is the current stock price of GRAIL, Inc. Common Stock (GRALV)?

As of the latest market data, GRAIL, Inc. Common Stock (GRALV) is trading at $18.63. The stock has seen a gain of 8.19% today.

Does GRAIL, Inc. Common Stock (GRALV) pay a dividend?

Based on current data, GRAIL, Inc. Common Stock does not have a confirmed active dividend policy.

What is the market cap of GRAIL, Inc. Common Stock?

The current market capitalization of GRAIL, Inc. Common Stock (GRALV) is approximately unavailable.

GRALV

GRAIL, Inc. Common Stock·Healthcare

18.63

8.188%(+1.41)

Market Closed

Last Updated: — ET

52W L: $12.5152W H: $23.36

Company Profile

GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. GRAIL, LLC was formerly known as PSC15, Inc. and changed its name to GRAIL, LLC in January 2016. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, LLC operates as a subsidiary of Illumina, Inc.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Beta

0.00

Websitegrail.com↗